C. Mesa

发表

Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.

J. Fagin, J. Knauf, Lei Zhang, 2005, Cancer research.

Apoptosis , Dedifferentiation , and Chromosomal Instability in Thyroid PCCL 3 Cells

J. Fagin, J. Knauf, Lei Zhang, 2005 .

BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.

J. Fagin, K. Taira, M. Miyagishi, 2006, Endocrinology.

Choosing Wisely for Thyroid Conditions: Recommendations of the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism

A. Maia, J. Dora, J. Cerutti, 2021, Archives of endocrinology and metabolism.

Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine.

C. A. Goedert, M. Olandoski, H. Graf, 2005, The Journal of clinical endocrinology and metabolism.

Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years

C. A. Goedert, G. Paz-Filho, H. Graf, 2008, Clinical endocrinology.

Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.

C. Tomlinson, M. Medvedovic, J. Fagin, 2006, Cancer research.

Preoperative embolization of thyroid arteries in a patient with large multinodular goiter and papillary carcinoma.

L. Noronha, H. Graf, H. Ramos, 2004, Thyroid : official journal of the American Thyroid Association.

Matrix Remodeling that Predict a Preferential Role of BRAF in Extracellular Thyroid Cells Is Associated with Gene Expression Profiles Conditional Activation of RET / PTC 3 and BRAFV 600 E in Updated

C. Tomlinson, M. Medvedovic, J. Fagin, 2006 .

Sonographically guided percutaneous ethanol treatment of a symptomatic complex nodule with a large cystic component in a patient with thyroid hemiagenesis

H. Graf, S. Basaria, C. Mesa, 2002, Journal of clinical ultrasound : JCU.

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

F. Vaisman, R. Corbo, D. Momesso, 2018, Archives of endocrinology and metabolism.